PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2018 | 5 | 1 | 10-15
Article title

Objawy okulistyczne w stwardnieniu rozsianym

Content
Title variants
EN
Ocular symptoms of multiple sclerosis
Languages of publication
PL
Abstracts
EN
Multiple sclerosis (MS) is the main reason of disability among young people in well-developed countries. One of the first symptoms of the disease is retrobulbar optic nerve inflammation. It appers that there is also a lot of other ocular symptoms in MS. Some of this symptoms occurs a few years before the diagnosis. Authors review all of the ocular symptoms in MS.
PL
Stwardnienie rozsiane (SM) to główna przyczyna niepełnosprawności u osób młodych w krajach wysoko rozwiniętych. Jednym z pierwszych, dominujących objawów choroby jest zapalenie nerwu wzrokowego w odcinku pozagałkowym. Ponadto w przebiegu SM dochodzi do wielu innych patologii w obrębie narządu wzroku, a niektóre z nich wyprzedzają diagnozę tej choroby o wiele lat. Autorzy postanowili zebrać i omówić wszystkie zaburzenia widzenia, jakie mogą wystąpić w przebiegu stwardnienia rozsianego.
Discipline
Publisher

Journal
Year
Volume
5
Issue
1
Pages
10-15
Physical description
Contributors
  • Klinika Okulistyki, Gdański Uniwersytet Medyczny
  • Klinika Okulistyki, Gdański Uniwersytet Medyczny
  • Klinika Okulistyki, Gdański Uniwersytet Medyczny
References
  • 1. Kalincik T. Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review. Neuroepidemiology 2015; 44: 199-214.
  • 2. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: The role of infection. Ann Neurol 2007; 61: 288-299.
  • 3. Toussaint D, Perier O, Verstappen A, et al. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3(3): 211-220.
  • 4. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the united states. Neurology 1976; 26(6 PT 2): 26-28.
  • 5. Cendrowski W. Stwardnienie rozsiane. PZWL, Warszawa 1993: 9-12.
  • 6. Stępień A. Neurologia, tom III. Medical Tribune Polska, Warszawa 2011: 183-195.
  • 7. Selmaj K. Stwardnienie rozsiane – kryteria diagnostyczne i naturalny przebieg choroby. Polski Przegląd Neurologiczny 2005; 3: 99-105.
  • 8. Zakrzewska-Pniewska B. Podstawy diagnostyki i leczenia stwardnienia rozsianego. Via Medica, Gdańsk 2010: 38-40.
  • 9. Andersen O. Natural history of multiple sclerosis. Saunders Elsevier 2008: 100-120.
  • 10. Halilovic EA, Alimanovic I, Suljic E, et al. Optic Neuritis a First Clinical Manifestations the Multiple Sclerosis. Mater Sociomed 2014; 26(4): 246-248.
  • 11. Balashow KE, Pal G, Rosenberg ML. Optic neuritis incidence is increased in spring months in patients with asymptomatic demyelinating lesions. Mult Scler 2010; 16(2): 252-254.
  • 12. Sobura-Ojeda A. Neuropatia demielinizacyjna nerwu wzrokowego. Przegląd Okulistyczny 2015; 5(67): 1-2.
  • 13. Kupersmith JM, Mandel G, Anderson S, et al. Acute Optic Imaging of the Peripapillary RNFL in Optic Neuritis – Alterations in Birefringence and Retardance Properties. Invest Ophthalmol Vis Sci 2008; 49: 5389.
  • 14. Obuchowska I. Współczesne aspekty diagnostyki i leczenia stwardnienia rozsianego z uwzględnieniem roli lekarza okulisty. Zeszyt edukacyjny „Kompendium Okulistyki” 2014; 2(10): 4-13.
  • 15. Roodhooft JM. Ocular problems in early stages of multiple sclerosis. Bull Soc Belge Ophtalmol 2009; 313: 65-68.
  • 16. Beyer AM, Rosche B, Pleyer U, et al. Stellenwert der Uveitis im Rahmen demyelinisierender Erkrankungen des Zentralnervensystems. Nervenarzt 2007; 78: 1389-1398.
  • 17. Le Scanff J, Seve P, Renoux C, et al. Uveitis associated with multiple sclerosis. Mult Scler 2008; 14: 415-417.
  • 18. Chen L, Gordon LK. Ocular manifestations of multiple sclerosis. Curr Opin Ophthalmol 2005; 16: 315-320.
  • 19. Cerovski B, Vidović T, Petriček I, et al. Multiple sclerosis and neuro-ophthalmologic manifestations. Coll Antropol 2005; 29(Suppl 1): 153-158.
  • 20. Balcer LJ, Miller DH, Reingold SC, et al. Vision and vision-related outcome measures in multiple sclerosis. Brain 2015; 138(1): 11-27.
  • 21. Cole SR, Beck RW, Moke PS, et al. The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. Invest Ophthalmol Vis Sci 2000; 41: 1017-1021.
  • 22. Sergott RC, Frohman E, Glanzman R, et al. The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci 2007; 263(1): 3-14.
  • 23. Trip SA, Schlottmann PG, Jones SJ, et al. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-391.
  • 24. Trip SA, Wheeler-Kingshott C, Jones SJ, et al. Optic nerve diffusion tensor imaging in optic neuritis. Neuroimage 2006; 30: 498-505.
  • 25. Fisher JB, Jacobs DA, Markowitz CE, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-332.
  • 26. Hickman SJ, Brex PA, Brierley CM, et al. Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence. Neuroradiology 2001; 43: 123-128.
  • 27. Costello F, Coupland S, Hodge W, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-969.
  • 28. Pro MJ, Pons ME, Liebmann JM, et al. Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis. J Neurol Sci 2006; 250: 114-119.
  • 29. Saidha S, Syc SB, Durbin MK, et al. Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler 2011; 17(12): 1449-1463.
  • 30. Burkholder BM, Osborne B, Loguidice MJ, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 2009; 66: 1366-1372.
  • 31. Saidha S, Eckstein C, Ratchford JN. Optical coherence tomography as a marker of axonal damage in multiple sclerosis. CML – Multiple Sclerosis 2010; 2: 33-43.
  • 32. Papakostopoulos D, Fotiou F, Hart JC, et al. The electroretinogram in multiple sclerosis and demyelinating optic neuritis. Electroencephalogr Clin Neurophysiol 1989; 74: 1-10.
  • 33. Saidha S, Syc SB, Ibrahim MA, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134: 518-533.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-5a17173d-0502-41cf-9aac-25d9e27d12c4
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.